HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lydia Chen Selected Research

SH2 Domain-Containing Protein Tyrosine Phosphatases

5/2022Pharmaceutical SH2 domain-containing protein tyrosine phosphatase 2 inhibition suppresses primary and metastasized liver tumors by provoking hepatic innate immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lydia Chen Research Topics

Disease

1Liver Neoplasms (Liver Cancer)
05/2022
1Neoplasms (Cancer)
05/2022
1Spinal Cord Injuries (Spinal Cord Injury)
10/2021
1Quadriplegia (Spastic Quadriplegia)
10/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019
1Lung Neoplasms (Lung Cancer)
11/2019
1Wounds and Injuries (Trauma)
01/2018
1Skin Neoplasms (Skin Cancer)
01/2018

Drug/Important Bio-Agent (IBA)

1SH2 Domain-Containing Protein Tyrosine PhosphatasesIBA
05/2022
1Pharmaceutical PreparationsIBA
05/2022
12-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
10/2021

Therapy/Procedure

1Precision Medicine
11/2019
1Therapeutics
11/2019
1Negative-Pressure Wound Therapy
01/2018